Elizabeth H.Z. Thompson
CIK 1861477 · EVP, Head of Research & Dev · last filed 2026-03-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$69.2K
Companies
3
Total Filings
23
Lifetime Open-Market Net
-$2.33M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACAD | EVP, Head of Research & Dev | 3,280 | $21.09 | $69.2K | -$73.7K | 4 | 2026-03-26 |
| IGM Biosciences, Inc. (IGMS) Delisted | Director | 0 | $1.27 | $0 | $0 | 9 | 2025-08-14 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | EVP, Research & Development | 0 | $116.30 | $0 | -$2.26M | 10 | 2023-10-06 |
Recent Filings · Page 3 of 3
23 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-06 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +6,969 | -$715.9K | EDGAR |
| 2021-08-06 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Sell (S) | −7,542 | -$802.0K | EDGAR |
| 2021-07-02 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +6,089 | -$578.4K | EDGAR |
Showing 21–23 of 23
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.